塞马格卢提德改善了与代谢功能障碍相关的脂肪肝炎:一项为期10年的回顾性研究
Parth Shah1, Megan White1, Alex Sievert2
1Division of Gastroenterology Washington University in Saint Louis Saint Louis Missouri USA.
JGH open : an open access journal of gastroenterology and hepatology
|February 23, 2024
概括
在患有代谢功能障碍相关的脂肪肝炎 (MASH) 的患者中,塞马格卢提德改善了肝酶和MASH得分. 这些好处与更长的治疗时间有关,而不是体重减轻.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 代谢功能障碍相关的脂肪肝炎 (MASH) 与炎症有关,而塞马格卢提德正在探索潜在的益处.
- 临床前数据表明,随着黄胺的使用,MASH的改善可能独立于减肥.
研究的目的:
- 评估塞马格卢提德对MASH的影响.
- 为了确定MASH的改善是否与减肥有关.
主要方法:
- 对420名糖尿病患者进行了回顾性分析,他们接受了12个月或更长时间的塞马格卢提德治疗.
- 排除患有其他肝病,不补偿性肝硬化,恶性瘤或减肥手术的患者.
- 主要终点:AST/ALT的临床显著改善;次要:MASH得分 (NFS,FIB4,APRI).
主要成果:
- 塞马格卢提德治疗 (平均22.5个月,1毫克/周为80%) 改善了BMI,体重,AST和ALT.
- 在28%/22%的患者中观察到AST/ALT的临床显著改善.
- MASH分数显著改善 (p < 0.001);改善独立于BMI或体重减轻百分比.
结论:
- 塞马格卢提德治疗在改善氨酸酶和MASH分数方面表现出有效性.
- 较长的治疗持续时间与更好的结果相关,独立于体重减轻.
相关概念视频
01:23Dipeptidyl Peptidase 4 Inhibitors
187
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
187
01:29Chronic Pancreatitis II: Collaborative Care
90
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
90
01:30Acute Pancreatitis II: Clinical Manifestations and Management
124
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
124